LINEOMAM LC, Intramammary solution
LINEOMAM LC, Intramammary solution
Authorised
- Lincomycin
- NEOMYCIN SULFATE
Product identification
Medicine name:
LINEOMAM LC, Intramammary solution
LINEOMAM LC, 330 mg/10 mL + 100000 i.j./10 mL, intramamarna otopina
Active substance:
- Lincomycin
- NEOMYCIN SULFATE
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Lincomycin330.00milligram(s)1.00Applicator
-
NEOMYCIN SULFATE100000.00international unit(s)1.00Applicator
Pharmaceutical form:
-
Intramammary solution
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (lactating cow)
-
Meat and offal3day
-
Milk84hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RF03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Available only in Croatian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/21-01/130
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0138/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Cyprus
-
Estonia
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 10/05/2023
How useful was this page?: